ArticleCancer immunology, immunotherapy : CII2023

Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.

Javier García-Corbacho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.